Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
Verma S, Leiter LA, Mazer CD, Bain SC, Buse J, Marso S, Nauck M, Zinman B, Bosch-Traberg H, Rasmussen S, Michelsen MM, Bhatt DL. Verma S, et al. Among authors: mazer cd. Circulation. 2018 Oct 9;138(15):1605-1607. doi: 10.1161/CIRCULATIONAHA.118.036862. Circulation. 2018. PMID: 30354517 No abstract available.
Subclinical Valve Thrombosis in Sutureless Bioprosthetic Valves.
Yanagawa B, Verma S, Mazer CD. Yanagawa B, et al. Among authors: mazer cd. J Am Heart Assoc. 2017 Aug 21;6(8):e006862. doi: 10.1161/JAHA.117.006862. J Am Heart Assoc. 2017. PMID: 28862965 Free PMC article. No abstract available.
Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
Verma S, Mazer CD, Al-Omran M, Inzucchi SE, Fitchett D, Hehnke U, George JT, Zinman B. Verma S, et al. Among authors: mazer cd. Circulation. 2018 Jan 23;137(4):405-407. doi: 10.1161/CIRCULATIONAHA.117.032031. Epub 2017 Nov 13. Circulation. 2018. PMID: 29133602 Clinical Trial. No abstract available.
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial.
Verma S, Mazer CD, Fitchett D, Inzucchi SE, Pfarr E, George JT, Zinman B. Verma S, et al. Among authors: mazer cd. Diabetologia. 2018 Aug;61(8):1712-1723. doi: 10.1007/s00125-018-4644-9. Epub 2018 May 19. Diabetologia. 2018. PMID: 29777264 Free PMC article. Clinical Trial.
The perils of polyvascular disease in type 2 diabetes.
Verma S, Mazer CD, Bhatt DL. Verma S, et al. Among authors: mazer cd. Lancet Diabetes Endocrinol. 2018 Dec;6(12):914-916. doi: 10.1016/S2213-8587(18)30311-5. Epub 2018 Nov 2. Lancet Diabetes Endocrinol. 2018. PMID: 30396866 No abstract available.
Pump, pipes, and filter: do SGLT2 inhibitors cover it all?
Verma S, Jüni P, Mazer CD. Verma S, et al. Among authors: mazer cd. Lancet. 2019 Jan 5;393(10166):3-5. doi: 10.1016/S0140-6736(18)32824-1. Epub 2018 Nov 10. Lancet. 2019. PMID: 30424891 No abstract available.
317 results